These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36527826)

  • 21. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D; Benedik E; Brecelj J; Orel R
    Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
    Pigneur B; Lepage P; Mondot S; Schmitz J; Goulet O; Doré J; Ruemmele FM
    J Crohns Colitis; 2019 Jul; 13(7):846-855. PubMed ID: 30541015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
    Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
    J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
    Luo YY; Fang YH; Yu JD; Xu LJ; Sun MF; Cheng Q; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):626-630. PubMed ID: 35762427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.
    Yu Y; Chen KC; Chen J
    World J Pediatr; 2019 Feb; 15(1):26-36. PubMed ID: 30666565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
    An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful Dietary Therapy in Paediatric Crohn's Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy Controls.
    Verburgt CM; Dunn KA; Ghiboub M; Lewis JD; Wine E; Sigall Boneh R; Gerasimidis K; Shamir R; Penny S; Pinto DM; Cohen A; Bjorndahl P; Svolos V; Bielawski JP; Benninga MA; de Jonge WJ; Van Limbergen JE
    J Crohns Colitis; 2023 Jan; 17(1):61-72. PubMed ID: 36106847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease.
    Connors J; Dunn KA; Allott J; Bandsma R; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    ISME J; 2020 Mar; 14(3):702-713. PubMed ID: 31796936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
    Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
    Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease.
    Hart L; Farbod Y; Szamosi JC; Yamamoto M; Britz-McKibbin P; Halgren C; Zachos M; Pai N
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.
    Dunn KA; Moore-Connors J; MacIntyre B; Stadnyk A; Thomas NA; Noble A; Mahdi G; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    Inflamm Bowel Dis; 2016 Nov; 22(11):2607-2618. PubMed ID: 27760077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products.
    Kerbiriou C; Dickson C; Nichols B; Logan M; Mascellani A; Havlik J; Russell RK; Hansen R; Milling S; Gerasimidis K
    Inflamm Bowel Dis; 2024 Dec; 30(12):2457-2466. PubMed ID: 38982655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive enteral nutrition for inducing remission in inflammatory bowel disease in paediatric patients.
    Assa A; Shamir R
    Curr Opin Clin Nutr Metab Care; 2017 Sep; 20(5):384-389. PubMed ID: 28768295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
    Cuomo M; Carobbio A; Aloi M; Alvisi P; Banzato C; Bosa L; Bramuzzo M; Campanozzi A; Catassi G; D'Antiga L; Di Paola M; Felici E; Fioretti MT; Gatti S; Graziano F; Lega S; Lionetti P; Marseglia A; Martinelli M; Musto F; Sansotta N; Scarallo L; Zuin G; Norsa L
    Inflamm Bowel Dis; 2023 Sep; 29(9):1380-1389. PubMed ID: 36222487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.